Free Trial

TerrAscend Q1 2023 Earnings Report

TerrAscend logo
$0.69 +0.13 (+24.34%)
(As of 12/17/2024 ET)

TerrAscend Earnings Headlines

TerrAscend (OTCMKTS:TSNDF) Cut to "Hold" at Atb Cap Markets
Analysts Issue Forecasts for TerrAscend FY2025 Earnings
Is the Trump/Musk duo good for shares of TSLA?
If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.
TerrAscend Reports Third Quarter 2024 Financial Results
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

View TerrAscend Profile

More Earnings Resources from MarketBeat

Upcoming Earnings